Earnings Feed
Start Free
Home/Filings/4/0000914190-15-000295
4//SEC Filing

BIO-TECHNE Corp 4

Accession 0000914190-15-000295

$TECHCIK 0000842023operating
View on SEC.govCompany Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:40 PM ET

Size

24.0 KB

Accession

0000914190-15-000295

Insider Transaction Report

Form 4
Period: 2015-08-07
BIO-TECHNE CorpTECH
VERONNEAU MARCEL
VP-Hematology Operations
Transactions
  • Award

    Restricted Stock Units

    2015-08-07+600→ 600 total
    → Common Stock (600 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-08-07+3,750→ 3,750 total
    Exercise: $108.49Exp: 2022-08-07→ Common Stock (3,750 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-08-07+7,500→ 7,500 total
    Exercise: $108.49Exp: 2022-08-07→ Common Stock (7,500 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $76.15Exp: 2018-07-27→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $76.02Exp: 2020-07-31→ Common Stock (15,000 underlying)
    15,000

  • Common Stock

    (indirect: by Stock Bonus Plan)
    6,827

  • Stock Option (Right to Buy)

    Exercise: $62.46Exp: 2016-07-23→ Common Stock (494 underlying)
    494

  • Stock Option (Right to Buy)

    Exercise: $76.15Exp: 2018-08-27→ Common Stock (1,129 underlying)
    1,129

  • Stock Option (Right to Buy)

    Exercise: $66.25Exp: 2017-04-29→ Common Stock (10,000 underlying)
    10,000

  • Stock Option (Right to Buy)

    Exercise: $74.05Exp: 2019-07-26→ Common Stock (1,097 underlying)
    1,097

  • Common Stock

    34,913

  • Stock Option (Right to Buy)

    Exercise: $58.40Exp: 2017-07-29→ Common Stock (1,281 underlying)
    1,281

  • Stock Option (Right to Buy)

    Exercise: $94.35Exp: 2021-08-12→ Common Stock (15,000 underlying)
    15,000
Footnotes (6)
  • [F1]Fully exercisable.
  • [F2]Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.
  • [F3]Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.
  • [F4]Vests 1,875 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F6]Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.

Documents

2 files

Issuer

BIO-TECHNE Corp

CIK 0000842023

→
Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000842023

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:40 PM ET
Size
24.0 KB
View on SEC.gov